{
    "code": "56030540",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56030540",
    "time": "2023-02-24 05:18:23",
    "許可證字號": "衛部醫器輸字第030540號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD4221",
    "有效日期": "117\/04\/19",
    "發證日期": "107\/04\/19",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05603054003",
    "中文品名": "尼奧溶小體儲積症質譜分析套組",
    "英文品名": "NeoLSD MSMS Kit",
    "效能": "用於定量新生兒採檢血片中的acid-β-galactocerebrosidase(ABG)，acid-sphingomyelinase(ASM)，acid-α-glucosidase(GAA)，β-galactocerebrodidase(GALC)，α-galactosidase A(GLA)，α-L-iduronidase(IDUA)之酵素活性。前途酵素活性之分析可幫助新生兒進行溶小體儲積症(LSD)篩檢，包含高雪式症、尼曼匹克症、龐貝氏症、Krabbe式症、法布瑞氏症及黏多醣一型。",
    "醫器規格": "3093-0010，以下空白。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B4020分析特定試劑",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "6201185824  豐技生物科技股份有限公司",
    "申請商地址": "台北市中正區紹興北街5號5樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "MFI0017100  WALLAC OY",
            "製造廠廠址": "MUSTIONKATU 6, FI 20750 TURKU, FINLAND",
            "製造廠公司地址": "",
            "製造廠國別": "FINLAND",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "5600305400001-107-05-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030540&Seq=001&Type=9"
        },
        {
            "title": "5600305400002-107-05-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56030540&Seq=001&Type=8"
        }
    ]
}